Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel®

被引：0
|
作者：
Laura S. Gold
Kangho Suh
Patricia B. Schepman
Kavitha Damal
Ryan N. Hansen
机构：
[1] University of Washington,Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program
[2] University of Washington,Department of Radiology, Pharmaceutical Outcomes Research and Policy Program
[3] Regional Outcomes,Department of Health Services, Pharmaceutical Outcomes Research and Policy Program
[4] Sanofi U.S.,undefined
[5] Santen Incorporated,undefined
[6] University of Washington,undefined
来源：
Advances in Therapy | 2016年 / 33卷
关键词：
Costs; H.P. Acthar; gel (repository corticotropin injection); Healthcare resource utilization; Intravenous immunoglobulin; Multiple sclerosis; Neurology; Plasmapheresis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1279 / 1292
页数：13
相关论文
共 50 条
  • [1] Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with HP Acthar Gel®
    Gold, Laura S.
    Suh, Kangho
    Schepman, Patricia B.
    Damal, Kavitha
    Hansen, Ryan N.
    ADVANCES IN THERAPY, 2016, 33 (08) : 1279 - 1292
  • [2] Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with H.P. Acthar Gel®
    Laura S. Gold
    Patricia B. Schepman
    Wei-Jhih Wang
    Michael Philbin
    John Niewoehner
    Kavitha Damal
    Ryan N. Hansen
    Advances in Therapy, 2016, 33 : 1293 - 1304
  • [3] Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with HP Acthar Gel®
    Gold, Laura S.
    Schepman, Patricia B.
    Wang, Wei-Jhih
    Philbin, Michael
    Niewoehner, John
    Damal, Kavitha
    Hansen, Ryan N.
    ADVANCES IN THERAPY, 2016, 33 (08) : 1293 - 1304
  • [4] H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes
    Kutz, Christen
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (04) : 190 - 197
  • [5] Multiple sclerosis: relapses, resource use, and costs
    Hawton, A. J.
    Green, C.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2016, 17 (07): : 875 - 884
  • [6] Multiple sclerosis: relapses, resource use, and costs
    A. J. Hawton
    C. Green
    The European Journal of Health Economics, 2016, 17 : 875 - 884
  • [7] Healthcare Resource Utilization and Costs of Multiple Sclerosis in Canada by Disability
    Metz, Luanne
    Greenfield, Jamie
    Marrie, Ruth-Ann
    Jette, Nathalie
    Suchowersky, Oksana
    Svenson, Larry
    Alikhani, Katayoun
    Khan, Maheer
    Gholizadeh, Shervin
    Xue, Cloris
    NEUROLOGY, 2017, 88
  • [8] Evaluating Treatment Patterns, Relapses, Healthcare Resource Utilization, and Costs Associated with Disease-Modifying Treatments for Multiple Sclerosis in DMT-Naive Patients
    Freeman, Leorah
    Kee, Arianna
    Tian, Marc
    Mehta, Rina
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 65 - 75
  • [9] Healthcare resource utilization and costs for extended interval dosing of natalizumab in multiple sclerosis
    Moccia, Marcello
    Loperto, Ilaria
    Santoni, Laura
    Masera, Silvia
    Affinito, Giuseppina
    Carotenuto, Antonio
    Lanzillo, Roberta
    Triassi, Maria
    Morra, Vincenzo Brescia
    Palladino, Raffaele
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2022, 12 (03) : 109 - 116
  • [10] HEALTHCARE RESOURCE UTILIZATION AND COSTS OF RENAL IMPAIRMENT IN PATIENTS WITH MULTIPLE MYELOMA
    Bhowmik, D.
    Song, X.
    Intorcia, M.
    Kent, S. T.
    Shi, N.
    VALUE IN HEALTH, 2017, 20 (05) : A358 - A358
12345